月別アーカイブ: 2014年1月

Research and Markets: Concise Analysis on the International Pharmacy Automation Market – Forecasts to 2016

DUBLIN–(BUSINESS WIRE)–

Research and Markets (http://www.researchandmarkets.com/research/2j9399/global_pharmacy) has announced the addition of the “Concise Analysis on the International Pharmacy Automation Market – Forecasts to 2016″ report to their offering.

Increasing customer support services is one of the emerging trends in the Global Pharmacy Automation market. The vendors in the Global Pharmacy Automation market are providing all-inclusive customer support packages with the purchase or rental of pharmacy automation systems. Staff technicians are available toll-free 24 hours a day, 365 days a year for personalized technical support and operational guidance. Some of the vendors provide automated updates of the software and drug database which are included in the support package. Vendors are offering the end-users with several maintenance and post-purchase services to retain the customer base and to remain competitive in the market.

The increase in technological innovations is one of the major drivers in the global pharmacy automation market. The demand for pharmacy automation products has increased significantly due to the technological advancements and sophisticated approaches in healthcare industry. Ongoing innovations are contributing to various healthcare operations on a regular basis. There has been increased emphasis on improving medication distribution by the companies and the pharmacies have become more receptive in accepting the same. The market is also expected to be driven by the introduction of advanced robotic prescription dispensing systems, central-fill systems, electronic-prescribing (e-prescribing), telehealth and automated kiosks during the forecast period.

Further, the report discusses that intense competition among vendors is one of the major challenges in the Global Pharmacy Automation market.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Market Coverage

4. Market Landscape

5. Geographical Segmentation

6. Vendor Landscape

7. Buying Criteria

8. Market Growth Drivers

9. Drivers and their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis

14. Other Reports in this Series

Companies Mentioned:

  • CareFusion
  • Kirby Lester
  • McKesson
  • Omnicell
  • Parata Systems
  • ScriptPro
  • Swisslog Holdings

For more information visit http://www.researchandmarkets.com/research/2j9399/global_pharmacy

Source Article from http://finance.yahoo.com/news/research-markets-concise-analysis-international-125500241.html
Research and Markets: Concise Analysis on the International Pharmacy Automation Market – Forecasts to 2016
http://finance.yahoo.com/news/research-markets-concise-analysis-international-125500241.html
http://news.search.yahoo.com/news/rss?p=pharmacy
pharmacy – Yahoo News Search Results
pharmacy – Yahoo News Search Results





Horizon Pharma (HZNP) Catches Eye: Stock Soars 18.2%

Horizon Pharma, Inc. (HZNP) was a big mover last session with shares rising over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up nearly 34% in the past one-month time frame.

This specialty pharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t remained in trend either. Yesterday’s sharp climb is encouraging though, so make sure to keep a close watch on this firm in the near future.

Horizon Pharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the biomedical industry include Affymetrix Inc. (AFFX), Actelion Ltd. (ALIOF) and Gentium S.p.A (GENT). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

HORIZON PHARMA INC (HZNP): Free Stock Analysis Report

AFFYMETRIX INC (AFFX): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report

Zacks Investment Research

Source Article from http://finance.yahoo.com/news/horizon-pharma-hznp-catches-eye-101502045.html
Horizon Pharma (HZNP) Catches Eye: Stock Soars 18.2%
http://finance.yahoo.com/news/horizon-pharma-hznp-catches-eye-101502045.html
http://news.search.yahoo.com/news/rss?p=pharma
pharma – Yahoo News Search Results
pharma – Yahoo News Search Results



Pharma-Bio Serv Announces Record Total Net Revenues of $33.1 Million and Record Net Income of $4.9 Million for the …

DORADO, PUERTO RICO–(Marketwired – Jan 29, 2014) –  Pharma-Bio Serv (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, recently announced record total net revenues of $33.1 million for the year ended October 31, 2013, an increase of approximately $3.8 million, or 13%, compared to 2012. The United States consulting market division and the Lab led the revenue improvement for the year ended October 31, 2013 with an increase in revenues of $2.2 and $1.0 million, respectively, when compared to 2012. Other company divisions sustained minor revenue changes or remained constant, when compared to 2012. The revenue growth, offset by the increase in operational support and business development expenses, resulted in record net income of approximately $4.9 million for the year ended October 31, 2013, an increase of $0.2 million, or 4.7%, when compared with 2012.

Selling, general and administrative expenses for the year ended October 31, 2013 were approximately $5.7 million, a net increase in expenses of approximately $1.6 million as compared to 2012.

“Our record results from operations are a testament to our focus on core value drivers across our business horizons,” said Elizabeth Plaza, Chairman of the Board of Directors. “We continue to enhance our strengths while executing on our strategic vision,” she added.

About Pharma-Bio Serv Inc.

Pharma-Bio Serv is a compliance, project management and technology transfer support consulting firm, headquartered in Puerto Rico, with operations in the U.S., Ireland and Spain. Pharma-Bio Serv’s core business is FDA and international agencies regulatory compliance related services with integrated portfolio services including microbiological and chemical testing services for clients in the Pharmaceutical, Biotechnology, Chemical, Medical Device, Cosmetic, Food and Allied Products industries, at its laboratory testing facility in Puerto Rico. Services also include “Integratek,” an information technology consulting practice, and “Pharma Serv Academy” a division that provides technical and regulatory standards seminars/training conducted by industry experts. The Company’s global team includes more than 300 leading engineering and life science professionals, quality assurance managers and directors.

Forward Looking Statements

This news release contains “forward-looking statements” within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are based on the expectations, estimates, or projections of management as of the date of this news release. Although Pharma-Bio Serv’s management believes these expectations, estimates, or projections to be reasonable as of the date of this news release, forward-looking statements are inherently subject to significant business risks, economic and competitive uncertainties, or other contingencies, which could cause its actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause Pharma-Bio Serv’s actual results or performance to differ materially from the forward-looking statements include those set forth in the “Risk Factors” section of Pharma-Bio Serv’s Annual Report on Form 10-K for the year ended October 31, 2013 and in its other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. Pharma-Bio Serv disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.

Source Article from http://finance.yahoo.com/news/pharma-bio-serv-announces-record-212326163.html
Pharma-Bio Serv Announces Record Total Net Revenues of $33.1 Million and Record Net Income of $4.9 Million for the …
http://finance.yahoo.com/news/pharma-bio-serv-announces-record-212326163.html
http://news.search.yahoo.com/news/rss?p=pharma
pharma – Yahoo News Search Results
pharma – Yahoo News Search Results